✦ LIBER ✦

Non-Hodgkin's lymphoma: Recent observations on natural history and intensive treatment

✍ Scribed by Paul P. Carbone

Publisher: John Wiley and Sons
Year: 1972
Tongue: English
Weight: 462 KB
Volume: 30
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197212)30:6<1511::aid-cncr2820300615>3.0.co;2-t

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Post-therapeutic acute malignant myelopr

Post-therapeutic acute malignant myeloproliferative syndrome and acute nonlymphocytic leukemia in non-Hodgkin's lymphoma correlation with intensity of treatment

✍ German A. Gomez; Kamlesh K. Aggarwal; Tin Han 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 2 views

Primary breast non-Hodgkin's lymphoma: A

Primary breast non-Hodgkin's lymphoma: A large single center study of initial characteristics, natural history, and prognostic factors

✍ Patricia Validire; Mathieu Capovilla; Bernard Asselain; Youlia Kirova; Rémi Goud 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Treatment of localized non-hodgkin's lym

Treatment of localized non-hodgkin's lymphomas of the head and neck: Focusing on cases of non-lethal midline granuloma

✍ Koh-ichi Sakata; Masato Hareyama; Atushi Oouchi; Mitsuo Sido; Hisayasu Nagakura; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 2 views

This report clarifies the prognostic factors for survival in localized non-Hodgkin's lymphoma (NHL) of the head and neck and defines optimal regimens for this disease. One hundred-seven untreated patients with Stage I or II NHL of the head and neck were treated with involved field radiation therapy

A phase II trial of teniposide (VM 26) i

A phase II trial of teniposide (VM 26) in advanced non-Hodgkin's lymphoma, with emphasis on the treatment of elderly patients

✍ Dr. Umberto Tirelli; Antonino Carbone; Diana Crivellari; Rachele Volpe; Giovanni 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB 👁 2 views

A pilot study on the use of the proMACE-

A pilot study on the use of the proMACE-cytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma

✍ Luca Baldini; Andrea Guffanti; Paolo Gobbi; Mariangela Colombi; Massimo Federico 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

## Background: The role of intensive conventional dose chemotherapy in advanced low grade non-hodgkin's lymphomas is a matter of debate. the gruppo italiano per lo studio dei linfomi conducted a study to evaluate the efficacy and toxicity of a third-generation polychemotherapeutic regimen, promace-